.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Accenture
AstraZeneca
Chinese Patent Office
Covington
Healthtrust
Julphar
Moodys
US Department of Justice
Cantor Fitzgerald

Generated: June 24, 2017

DrugPatentWatch Database Preview

MEZLIN Drug Profile

« Back to Dashboard

Which patents cover Mezlin, and what generic Mezlin alternatives are available?

Mezlin is a drug marketed by Bayer Pharms and is included in four NDAs.

The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.

Summary for Tradename: MEZLIN

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list28
Patent Applications: see list3,006
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEZLIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062333-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION050549-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062333-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION062372-002May 13, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
MEZLIN
mezlocillin sodium monohydrate
INJECTABLE;INJECTION050549-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Merck
Citi
Accenture
McKesson
Farmers Insurance
Express Scripts
Harvard Business School
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot